Submitted:
02 July 2024
Posted:
04 July 2024
Read the latest preprint version here
Abstract
Keywords:
1. Introduction
2. Materials and Methods
Search Strategy
Study Selection
Eligibility Criteria
Screening and Data Extraction
3. Results
3.1. Study Selection and Characteristics
3.2. Baseline Characteristics
3.3. Surgical Outcome
3.4. Figures, Tables and Schemes

4. Discussion
Funding
Informed Consent Statement
Acknowledgments
Conflicts of Interest
Appendix A

| First Author (Year) | Study Type (Method) | Study Population (s) (Controls and Patients) |
Clinical Presentation | Surgical Outcome | ||
|---|---|---|---|---|---|---|
| Non-Black | Black | Non-Black | Black | |||
| Goodney9 (2013) | Retrospective cohort study Intervention: Thoracic aneurysm repair Control: Mortality Data source: Medicare claims (1999-2007) |
N=722 black patients N= 14,583 non-black patients (97% White, 1.0% Native American, 0.9% Hispanic, 0.9% Asian American, 0.1% Pacific Islander, 0.1 % missing) |
Older presentation (74.5 vs 73,7; P=0 .001) 4,4% ruptured TAA. (7.3% vs 4.4%; P=0.001) Non-black patients had a higher ratio of men (56,4% vs. 43,4%; p=0,02) |
Younger presentation (74.5 vs 73.7; P= 0.001) 7,3% ruptured TAA (7.3% vs 4.4%; P=0.001) Black patients had a higher Charlson comorbidity score (1,51 vs 0,92; p=0,001) Black patients had a higher prevalence of diabetes, heart failure, renal failure and history of malignancy (p=0.001) |
Open surgical repair: lower perioperative mortality 6.8% non-black; P < 0.001. 5-year survival: 61% P < 0.001. |
Open surgical repair: higher perioperative mortality 14.4% black; P < 0.001. Operative mortality: OR 2.0; 95% CI 1.5-2.5; P < 0.0001. 5-year survival: 71%; P < 0.001. |
| Yin10 (2021) | Retrospective cohort study Intervention: Thoracic endovascular aneurysm repair Control: 30-day mortality Data source: VQI national data registry |
N= 684 black patients N= 2021 non-black patients (100% white) |
1488 aneurysms (73,6%) | More likely to undergo emergent TEVAR (27.6% vs. 19.8%; P < 0.001). More likely symptomatic (52.3% vs. 36.4%; P < 0.001). More likely to receive blood transfusion (32.1% vs. 23.6%; P < 0.001). |
30-Day Mortality: No significant difference in 30day mortality: (3.4% vs 4.9%; P =0.1) |
30-Day Mortality: Following correction for operative variables, comorbidities, and demographics: black race was independently associated with 56% decrease in risk after Tevar (OR 0.44; 95% CI 0.22-0.85; P = 0.01). Postoperative Complications: No independent association (OR 0.90; 95% CI 0.68-1.17; P = 0.42). 1-year overall survival: log-rank P= 0.024 1-year mortality Hr:0.65; 95% CI, 0.47-0.91; P=0.01 |
| Diaz-Castrillon11 (2022) | Retrospective cohort study Intervention: Thoracic endovascular aneurysm repair Control: In-hospital mortality Data source: Nationwide inpatient sample (NIS) 2010-2017 |
N= 4,959 black N=20,301 non-black (68,1% white, 5,7% Hispanic, 6,5% others) |
CAD more prevalent (34.6% (white) vs. 24.1% (black) vs. 26.8% (Hispanic) vs. 24.7% (others); p < .001). COPD more prevalent (28.7% vs. 15.6% vs. 15.1% vs. 16.5%; p < .001). TEVAR often times elective (58.8% vs. 34% vs. 48.3% vs. 48.2%; p < .001). |
Hypertension more frequent as a comorbidity (92% (black) vs. 83%(white) vs. 85% (Hispanic) vs. 84% (others); p < .001) | Racial disparities do not appear to be associated with in-hospital mortality. | Racial disparities do not appear to be associated with in-hospital mortality. |
| Tanious12 (2019) | Retrospective cohort study Intervention: Thoracic endovascular aneurysm repair Control: In-hospital mortality Data source: Florida State Agency for Health Care Administration 2000-2014 |
N= 1,630 black N= 34,119 non-black (47.7% White, 46.0% Hispanic,1.8%) other.) |
Older presentation 67,42 (black) vs. 73.87 (white) vs. 73,52 (Hispanic) vs. 72,06 (other); P< 0.001 |
Higher prevalence of women 31,5% (black) vs. 16,1 (white) vs. 20,2 (Hispanic) vs. 21,8 (other); P< 0.001 |
Chance of in-hospital mortality: 2,5% (white), 2,8% (Hispanic), 5,1% (other); p<0,0001 |
Chance of in-hospital mortality: 4,0%; P<0,0001 |
| Johnston13 (2013) | Retrospective cohort study Intervention: Thoracic endovascular aneurysm repair Control: TEVAR performance based on race Data source: Nationwide inpatient sample (NIS) 2005-2008 |
N= 4,108 black N = 41,122 non-black (86% white, 6,2% Hispanic, 3,2% Asian or Pacific Islander, 0,8% Native American, 3,7% other) |
NA | 28.6% of black patients received TEVAR, whereas only 19.5% of white patients were treated with TEVAR (P < .001) |
TEVAR performance: Odds ratio: Native American: 2.37 Black: 1.71 Hispanic: 1.70 Asian or Pacific Islander: 1.34 Other: 0.98 White (reference): 1 |
Tevar performance: Odds: Black: 1.71 |
| Murphy14 (2013) | Retrospective cohort study Intervention: Thoracic endovascular aneurysm repair Control: mortality Data source: Nationwide inpatient sample (NIS) 2001-2005 |
N=819 black N= 9,738 non-black (88% white, 5,7% Hispanic, 6,8 other) |
High prevalence for elective surgery: 48%; P < 0,001 |
High prevalence for emergency surgery: 20%; P < 0,001 |
Mortality rate: 9,8%; P < 0,001 | Mortality rate: 13,7%; P < 0,001 |
| Abdulameer15 (2019) | Retrospective cohort study Intervention: Thoracic aneurysm rupture Control: Mortality per million Data source: U.S. National Vital Statistics System 1999-2016 |
N=104,458 total ruptures | NA | NA | Mortality/ million White female: 3,5 White men: 3,3 Asian men: 1,5 Asian women: 2,5 (P<0,001) |
Mortality/ million Black female: 2.3 Black men: 2,6 (P<0,001) |
| Vervoort16 (2021) | Retrospective cohort study Intervention: Elective thoracic endovascular aneurysm repair Control: Reintervention and surgical outcome Data source: Vascular Quality Initiative 2009-2018 |
N= 2,140 black N= 40,431 Non-black (100% white) |
Female sex 33,8% (23), p=0.02 Aortic neck in mm 28,2+/-15,8 p=0,01 CHF: 6,0 (4) p=0,01 Smoking history: 89,7 (61) p < 0,01 |
Female sex 19,3% (212), p=0.02 Aortic neck in mm 23,8+/-5,25 p=0,01 CHF: 13,0 (143) p=0,01 Smoking history: 83,1 (911) p < 0,01 |
All-cause mortality: similar between groups (log-rank P = 0.25) Reintervention: White race statistically associated with reintervention; P = 0.01 |
All-cause mortality: similar between groups (log-rank P = 0.25) Reintervention: hr: 0,7; p=0,01 |
| Ribieras17 (2023) | Retrospective cohort study Intervention: thoracic endovascular aneurysm repair Control: All-couse mortality Data source: Global Registry for Endovascular Aortic Treatment (GREAT) 2010-2016 |
N= 79 black N=359 non-black |
Chronic obstructive pulmonary disease: Black 6.3% vs White 20.1%; P = 0.003 Cardiac arrhythmia: Black 10.1% vs White 20.6%; P = 0.037 |
Younger presentation: 62 years vs 67 years); P < 0.001. Higher BMI 31.0 kg/m2 vs 27.5 kg/m2); P < 0.001. Renal insufficiency: 35.4% vs 17.8%; P = 0.001. Higher incidence of erectile dysfunction in black patients 6.3% vs 2.0%; P = 0.047. Higher incidence of hypertension: common in black patients (100% vs 86.5%; P = 0.034). Higher prevalence of diabetes mellitus: 18.8% vs 4.5%; P = 0.021. |
All-cause mortality: no significant difference |
Complications: 34.3% vs 17.4%; P = 0.014 Conversion to open repair: 2.9% vs 0%; P = 0.011 Type II endoleaks: 5.7% vs 1.0%; P = 0.040 All-cause mortality: no significant difference |
| Murphy18 (2010) | Retrospective cohort study Intervention: Thoracic aneurysm rupture Control: Mortality Data source: U.S. National Vital Statistics System 2001-2005 |
N=104 black N= 699 non-black (93% white, 7% Hispanic) |
Male: 450/650 (white), 32/49 (Hispanic); P < 0,001 | Male: 54/104 P < 0,001 |
Overall mortality: 13.3% (n=117), no differences between patients of varied ethnicity Mortality: 12% (white), 10% (hispanic), 19% (other); p=303 |
Overall mortality: 13.3% (n=117), no differences between patients of varied ethnicity Mortality:12% died; p=0,303 |
| TEVAR thoracic endovascular aneurysm repair; | ||||||
References
- Harky, A., Sokal, P. A., Hasan, K., & Papaleontiou, A. (2020). The Aortic Pathologies: How far we understand it and its implications on thoracic aortic surgery. Brazilian Journal of Cardiovascular Surgery. [CrossRef]
- Gouveia E Melo R, Silva Duarte G, Lopes A, Alves M, Caldeira D, Fernandes E Fernandes R, Mendes Pedro L. Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies. Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):1-16. [CrossRef] [PubMed]
- Crousillat, D. R., Briller, J., Aggarwal, N. R., Cho, L., Coutinho, T., Harrington, C., Isselbacher, E. M., Lindley, K. J., Ouzounian, M., Preventza, O., Sharma, J., Sweis, R., Russo, M. L., Scott, N. S., & Narula, N. (2023). Sex differences in thoracic aortic disease and dissection. Journal of the American College of Cardiology, 82(9), 817–827. [CrossRef]
- Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121(13):e266–e369. [CrossRef]
- Erbel R , Aboyans V , Boileau C , Bossone E , Bartolomeo RD , Eggebrecht H et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873–926.
- Grewal N, Gittenberger-de Groot AC, Poelmann RE, Klautz RJ, Lindeman JH, Goumans MJ, Palmen M, Mohamed SA, Sievers HH, Bogers AJ, DeRuiter MC. Ascending aorta dilation in association with bicuspid aortic valve: a maturation defect of the aortic wall. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1583-90. [CrossRef] [PubMed]
- Grewal N, Klautz RJM, Poelmann RE. Intrinsic histological and morphological abnormalities of the pediatric thoracic aorta in bicuspid aortic valve patients are predictive for future aortopathy. Pathol Res Pract. 2023 Aug;248:154620. [CrossRef] [PubMed]
- Grewal N, Gittenberger-de Groot AC, Lindeman JH, Klautz A, Driessen A, Klautz RJM, Poelmann RE. Normal and abnormal development of the aortic valve and ascending aortic wall: a comprehensive overview of the embryology and pathology of the bicuspid aortic valve. Ann Cardiothorac Surg. 2022 Jul;11(4):380-388. [CrossRef] [PubMed] [PubMed Central]
- Chung, J., Coutinho, T., Chu, M., & Ouzounian, M. (2020). Sex differences in thoracic aortic disease: A review of the literature and a call to action. The Journal of Thoracic and Cardiovascular Surgery, 160(3), 656–660. [CrossRef]
- Page, M.J., McKenzie, J.E., Bossuyt, P.M. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10, 89 (2021). [CrossRef]
- Goodney, P. P., Brooke, B. S., Wallaert, J. B., Travis, L. L., Lucas, F. L., Goodman, D. C., Cronenwett, J. L., & Stone, D. H. (2013). Thoracic endovascular aneurysm repair, race, and volume in thoracic aneurysm repair. Journal of Vascular Surgery, 57(1), 56-63.e1. [CrossRef]
- Yin, K., Alhajri, N., Rizwan, M., Locham, S., Dakour-Aridi, H., & Malas, M. B. (2021). Black patients have a higher burden of comorbidities but a lower risk of 30-day and 1-year mortality after thoracic endovascular aortic repair. Journal of Vascular Surgery, 73(6), 2071-2080.e2. [CrossRef]
- Díaz-Castrillón, C. E., Serna-Gallegos, D., Aranda-Michel, E., Brown, J. A., Yousef, S., Thoma, F., Wang, Y., & Sultan, I. (2022). Impact of ethnicity and race on outcomes after thoracic endovascular aortic repair. Journal of Cardiac Surgery, 37(8), 2317–2323. [CrossRef]
- Tanious, A., Karunathilake, N., Toro, J., Abu-Hanna, A., Boitano, L. T., Fawcett, T. J., Graves, B., & Nelson, P. R. (2019). Racial disparities in endovascular aortic aneurysm repair. Annals of Vascular Surgery, 56, 46–51. [CrossRef]
- Johnston, W. F., LaPar, D. J., Newhook, T. E., Stone, M. L., Upchurch, G. R., & Ailawadi, G. (2013). Association of race and socioeconomic status with the use of endovascular repair to treat thoracic aortic diseases. Journal of Vascular Surgery, 58(6), 1476–1482. [CrossRef]
- Murphy, E. H., Stanley, G. A., Arko, M. Z., Davis, C. M., Modrall, J. G., & Arko, F. R. (2013). Effect of ethnicity and insurance type on the outcome of open thoracic aortic aneurysm repair. Annals of Vascular Surgery, 27(6), 699–707. [CrossRef]
- Abdulameer, H., Taii, H. A., Al-Kindi, S., & Milner, R. (2019). Epidemiology of fatal ruptured aortic aneurysms in the United States (1999-2016). Journal of Vascular Surgery, 69(2), 378-384.e2. [CrossRef]
- Vervoort, D., Canner, J. K., Haut, E. R., Black, J. H., Abularrage, C. J., Zarkowsky, D. S., Iannuzzi, J. C., & Hicks, C. W. (2021). Racial disparities associated with reinterventions after elective endovascular aortic aneurysm repair. Journal of Surgical Research, 268, 381–388. [CrossRef]
- Ribieras, A. J., Challa, A. S., Kang, N., Kénel-Pierre, S., Rey, J., Velázquez, O. C., Milner, R., & Bornak, A. (2023). Race-based outcomes of thoracic aortic aneurysms and dissections in the Global Registry for Endovascular Aortic Treatment. Journal of Vascular Surgery, 78(5), 1190-1197.e2. [CrossRef]
- Murphy, E. H., Davis, C. M., Modrall, J. G., Clagett, G. P., & Arko, F. R. (2010). Effects of ethnicity and insurance status on outcomes after thoracic Endoluminal Aortic aneurysm Repair (TEVAR). Journal of Vascular Surgery, 51(4), S14–S20. [CrossRef]
- Deery SE, O’Donnell TFX, Shean KE, Darling JD, Soden PA, Hughes K, Wang GJ, Schermerhorn ML; Society for Vascular Surgery Vascular Quality Initiative. Racial disparities in outcomes after intact abdominal aortic aneurysm repair. J Vasc Surg. 2018 Apr;67(4):1059-1067. [CrossRef] [PubMed] [PubMed Central]
- Pandit, V., Nelson, P. R., Horst, V., Hanna, K., Jennings, W. C., Kempe, K., & Kim, H. (2020). Racial and ethnic disparities in patients with ruptured abdominal aortic aneurysm. Journal of Vascular Surgery, 72(1), e85. [CrossRef]
- Asfaw A, Ning Y, Bergstein A, Takayama H, Kurlansky P. Racial disparities in surgical treatment of type A acute aortic dissection. JTCVS Open. 2023 Feb 10;14:46-76. [CrossRef] [PubMed] [PubMed Central]
- Yammine H, Ballast JK, Anderson WE, Frederick JR, Briggs CS, Roush T, Madjarov JM, Nussbaum T, Sibille JA, Arko FR 3rd. Ethnic disparities in outcomes of patients with complicated type B aortic dissection. J Vasc Surg. 2018 Jul;68(1):36-45. [CrossRef] [PubMed]
- Racial and ethnic categories and definitions for NIH diversity programs and for other reporting purposes (NOT-OD-15-089). (2015). https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-089.html.
- Lu C, Ahmed R, Lamri A, Anand SS. Use of race, ethnicity, and ancestry data in health research. PLOS Glob Public Health. 2022 Sep 15;2(9):e0001060. [CrossRef] [PubMed] [PubMed Central]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).